L-Asparaginase delivery systems targeted to minimize its side-effects

Area of Science:

• Biochemistry and Enzymology
• Oncology and Hematology
• Biomaterials and Drug Delivery

Background:

• L-asparaginase (L-ASP) is crucial for treating Acute Lymphocytic Leukemia (ALL) by depleting L-asparagine, essential for leukemic cell survival.
• Conventional L-ASP therapy faces challenges including hypersensitivity, antigenicity, short half-life, and toxicity, limiting its clinical application.
• Enzyme immobilization strategies aim to mitigate these side effects and enhance therapeutic outcomes.

Purpose of the Study:

• To review current advancements in L-asparaginase (L-ASP) formulations designed to reduce adverse effects and improve safety.
• To highlight the benefits of enzyme encapsulation as a strategy for enhancing L-ASP's therapeutic profile.
• To discuss the impact of different encapsulation systems on enzyme activity, stability, and targeted delivery.

Main Methods:

• Review of existing literature on L-asparaginase (L-ASP) immobilization and formulation techniques.
• Comparison of enzyme modification strategies, focusing on covalent binding versus encapsulation.
• Analysis of encapsulation systems using materials like chitosan, alginate, and liposomes for L-ASP delivery.

Main Results:

• Enzyme encapsulation effectively shields L-ASP from immune responses, prolongs its in vivo half-life, and reduces toxicity.
• Encapsulation preserves the native tetrameric form of L-ASP, crucial for its anti-leukemic activity, unlike other modification methods.
• The choice of encapsulation system significantly influences the stability, activity, and targeted delivery of L-ASP formulations.

Conclusions:

• Encapsulation represents a promising strategy for developing safer and more effective L-asparaginase (L-ASP) formulations for Acute Lymphocytic Leukemia (ALL) treatment.
• Further research into selecting optimal encapsulation systems is critical for maximizing therapeutic performance and patient outcomes.
• Future trends focus on biodegradable materials, targeted delivery, and enhanced selectivity for L-ASP formulations.